1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €5.70 (+223.86%). The median is €6.04 (+243.18%).
| Buy |
5 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 2.57m | - |
| Gross profit | 2.57m | - |
| Net profit | -32.14m | - |
| EBITDA | -32.32m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €110.85m |
Number of shares | 62.96m |
52-week high/low | €3.30 - €1.06 |
| Dividends | No |
Beta | -0.22 |
P/E ratio | -2.32 |
PEG ratio | 0.03 |
P/B ratio | 4.78 |
P/S ratio | 43.73 |
Company profile
| Name | CONN.BIOPH.HLDGS ADS/1 |
| CEO | Barry D. Quart |
| Employees | 64 |
